Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001897612-25-000207
Filing Date
2025-05-14
Accepted
2025-05-14 10:47:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5806
  Complete submission text file 0001897612-25-000207.txt   7581
Mailing Address 3052 ORCHARD DRIVE SAN JOSE CA 95134
Business Address 3052 ORCHARD DRIVE SAN JOSE CA 95134 669-231-8200
Outset Medical, Inc. (Subject) CIK: 0001484612 (see all company filings)

EIN.: 200514392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91699 | Film No.: 25943483
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 1307 POINT STREET BALTIMORE MD 21231
Business Address 1307 POINT STREET BALTIMORE MD 21231 000-000-0000
T. Rowe Price Investment Management, Inc. (Filed by) CIK: 0001897612 (see all company filings)

EIN.: 854328500 | State of Incorp.: MD | Fiscal Year End: 1231
Type: SCHEDULE 13G/A